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oRIGINAL ARTICLE 
NALIDIXIC ACID SCREENING TEST IN DETECTION OF 
DECREASED FLUOROQUINOLONE SUSCEPTIBILITY IN 
SALlv10NELLA TYPHI ISOLATED FROM BLOOD 
Afia Zalar, Nazish Gullbrahim, Tanwir Ahsan, Zohair Abbas: Anita Zaidi' and Rumina Hasan 
ABSTRACT 
Objective: To determine the validity of nalidixic acid screening test in the detection of high MICs of fluoroquinolone 
against Salmoni!lla(S.) typhi isolated from blood and correlate zone diameters of ofloxacin with that of MIG value for 
nalidixic acid sensitive and resistant strains. 
Design: Cross-sectional analytical study. 
Place and Duration of Study: Clinical Microbiology Laboratory of the Aga Khan Hospital, Karachi from January 2002 
to December 2003. 
Patients and Methods: Two hundred S. typhi isolates from blood were included for nalidixic acid screening and 
ofloxacin susceptibility. Antibiotic susceptibilities for both the antibiotics were obtained by disc diffusion method 
whereas MICs were determined by standard agar dilution method as recommended by NCCLS guidelines. Sensitivity, 
specificity and correlation between both antimicrobial susceptibility methods were calculated and results expressed 
as scattergrams. 
Results: The results broadly classify S. typhi isolates into nalidixic acid resistant strains with no zone of inhibition 
around 30 /lg nalidixic acid disc and nalidixic acid sensitive strains with mean zone of inhibition of 24.9mm. All S. typhi 
isolates with ofloxacin MIG of ;,0.125 Jlg/ml were found to be nalidixic acid resistant (MIG ;o82 /lg/ml) whereas the 
isolates with ofloxacin MIG s0.06 flg/ml were nalidixic acid sensitive (MIG Sl /lg/ml). Screening for nalidixic acid 
resistance was found to be 100% sensitive and 97% specific in identifying s. typhi strains with reduced susceptibility 
to fluoroquinolone (MIG ;,0.125 Jlg/ml). 
Conclusion: Nalidixic acid resistance as a screening method is proved to be significant in identifying s. typhi isolates 
with reduced susceptibility to fluoroquinolones. It is also suggested that inhibition zone of s25mm around 5/lg 
ofloxacin disc is appropriate as a selection criterion to detect s. typhi isolates with reduced susceptibility to 
fluoroquinolones. 
KEY WORDS: Salmonella typhi. Fluoroquinolone resistance. Nalidixic acid screening blood isolates. 
INTRODUCTION 
Typhoid fever has long been endemic within South Asia. 
Multidrug-resistant Salmonella typhi (MDRST), defined as 
strains exhibiting en-bloc resistance to chloramphenicol, 
ampicillin and trimethoprim-sulfamethoxazole (TMP-SMX), 
was first reported from South Asia in late 80s.1.2 Multidrug 
resistant S. typhi is now endemic in our region3 along with 
overall increase in isolation rate and various reported 
compared to. intravenous ceftriaxone.B-14 Isolation rate of 
multidrug resistant S. typhi from Pakistan is reported to be 
arowi.d 40% to 67.9%14,15 which are uniformly susceptible to 
fluoroquinolones. 
· outbreaks."' 
Until recently, these multidrug-resistant strains have remained 
uniformly susceptible to fluoroquinolones and third 
generation cephalosporins. The two fluoroquinolones 
ofloxacin and ciprofloxacin are successful, safe, simple and 
costeffective mode of therapy with excellent cure rates as 
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A steady rise has, however, been observed in the incidence of 
fluoroquinolone resistant typhoid fever. These isolates have 
ofloxacin MICgo of 0.5 mg/L compared with 0.06 mg/L for 
fluoroquinolone susceptible isolates. Routine susceptibility 
methods as recommended by National Committee for Clinical 
Laboratory Standards (NCCLS)l' fail to detect higher MICs of 
f!uoroquinolones giving false susceptibility result, which 
appears to be responsible for growing number of treatment 
failures.I7 
Results showed that nalidixic acid resistant strains exhibited 
higher MIC values for ofloxacin and ciprofloxacin as 
compared to nalidixic acid sensitive strains despite the fact 
that these isolates were reported to be susceptible using 
recommended zone diameter from NCCLS.16-20 It is 
recommended that screening of all isolated S. typhi for nalidixic 
acid resistance should be conducted to alert physicians about 
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the possibility of treatment failure with fluoroquinolones.J7,20 
This study was conducted to explore the validity of nalidixic 
acid screening test in detection of high MICs of 
fluoroquinolone against Salmonella typhi isolated from blood in 
a tertiary care referral laboratory ID a typhoid endemic area. 
Our second objective was to correlate the zone diameters of 
ofloxacin with that of MIC values for both nalidixic acid 
sensitive and resistant straffis. 
pATIENTS AND METHODS 
Two hundred Salmonella typhi isolates from blood culture 
samples submitted to clinical microbiology laboratory 
between January 2002 to December 2003 were included in this 
study for nalidixic acid screening and fluoroquiDolone 
susceptibility. Isolates were identified by API20E (Bio Murex, 
France). Serological confirmation was done by slide and tube 
agglutination method using type specific antisera (Difco 
Laboratries). 
Antibiotic susceptibility of these isolates was determined by 
Kirby Bauer method using nalidixic acid (30!'g) and of!oxacin 
(5!'g) disks according to NCCLS (National Committee for 
Clinical Laboratory Standards) guidelines." Minimum 
inhibitory concentration (MIC) of ofloxacin was determined 
by standard agar dilution method using Mueller Hinton agar 
as described in NCCLS guidelines.21 E. coli ATCC strain 25922 
was used as control in susceptibility testing by agar dilution 
method. 
As per NCCLS recommendationsl6,21 Salmonella typhi isolates 
with inhibition zone diameter of ;, 19mm around 301'g 
nalidixic acid disk and minimum inhibitory concentration 
(MIC) of :s:161'g/ml by standard agar dilution method are 
classified as nalidixic acid sensitive Salmonella typhi , whereaS, 
isolates with inhibition zone diameter of :::13rrun aronnd 30p.g 
nalidixic acid disk and minimum inhibitory concentration of 
;,321'g/ml by standard agar dilution method are categorized 
as nalidixic acid resistant Salmonella typhi. Isolates with reduced 
susceptibility to fluoroquinolones is defined asS. typhi strains 
with the MIC of ;o,0.125!'g/ ml for ofloxacin by standard agar 
dilution method. 
Susceptibility data of all Salmonella typht isolates for the above 
mentioned antibiotics was analyzed by using descriptive 
statistics of SPSS software version 13.0. Mean inhibition zone 
diameter of ofloxacin (± standard deviation) has been 
calculated for both nalidixic acid sensitive and resistant 
strains. Software EpiCal 2000 was used for determination of p-
value which was considered to be significant if :50.01. Pearson 
correlation was calculated to demon.strate association between 
both the antimicrobial susceptibility methods against 
ofloxacin and nalidixic acid. Correlation was considered to be 
significant at 0.01 level (2-tailed). Sensitivity and specificity 
were calculated and results were expressed ID the form of 
scattergrams. 
RESULTS 
All S. typhi isolates included in the study {n=200) were tested 
for ofloxacin susceptibility by disc diffusion method and 
considered sensitive as per NCCLS recommendation 
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(inhibition zone diameter ;, 16). Mean inhibitory zone 
diameter aronnd nalidixic acid and ofloxacin disks are show:n 
in Table I along with p-values. These results broadly classify 
these isolates into two distinct subgroups; nalidixic acid 
resistant S. typhi with no zone of inhibition and nalidixic acid 
sensitiveS. typhi with mean zone diameter of 24.9mm arolll\d 
30!'g nalidixic acids disk (Table I). This difference between 
inhibition zone diameter aronnd nalidixic acid disk has been 
significant (p-value :5 0.01). Significant difference in zone 
diameter for ofloxacin by disc diffusion method was also 
observed for the above mentioned strains showing a definite 
association between nalidixic acid resistance and decreased 
f!uoroquinolone susceptibility. 
Table 1: Mean zone diameter around nalidixic acid and ofloxacin 
for S typhi strains isolated from blood 
Agent Nalidixic acid Nalidixic acid 
(disk content) resistant isolates sensitive isolates p-value 
(MIG ;B2pg/ml) (MIG 516pg/ml) 
Mean Range Mean Range 
±SD (mm) ±SD (mm) 
Nalidixic acid 
(30pg) 0±0 0 24.9±2.1 (19-38) ,0.01 
Ofloxacin 
(Spg) 22.6 ±1.5 (19-26) 27.7 ±2.6 (19-41) ,O.D1 
It was also observed that all isolates which were nalidixic acid 
resistant by both disc diffusion and MIC methods had their 
MIC values for ofloxacin ;o,0.1251'g/ml as compared to the 
nalidixic acid sensitive strains having MIC values of ~ 
0.06!'g/ml (Figure 1). When ofloxacin MIC of ;o,0.1251'g/ml 
was adopted as a breakpoint, nalidixic acid screening led to 
the detection of all S. typhi isolates with decreased 
fluoroguinolone susceptibility (p-value 0.01). 
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Figure 1: .MIG values ofloxacin versus nalidiXic acid. 
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Correlation between ofloxacin MICs and zone diameters 
around 5-mg disk of ofloxacin are shown in Figure 2. Ninety· 
eight out of 100 S. typhi strains for which ofloxacin MICs were 
between 0.125-0.51'g/ml had inhibition zone diameter of :5 25 
mm. Remaining two isolates had MIC of 0.125!'g/ml with the 
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.hllibition zone diameter of 30-32;;,;,;;- by disk diffusion 
method. Correlating the MIC of ofloxacin with that of nalidixic 
acid for the above mentioned isolates, all S. typhi isolates with 
ofloxacin MIC of 2:0.125 mg/ml were nalidixic acid resistant 
(MIC 2:32 f!g/ml), whereas, all S. typbi isolates with MIC of 
ofloxacin ,; 0.06ug/ ml had inhibition zone diameter of ;, 
4Smm around ofloxacin disk and had MIC values of 9l f!g/ ml 
ior _nalidixic acid and, therefore, considered sensitive. This 
2bh-eiation between nalidixic acid disk and ofloxacin M!Cs for 
aJ1 S. typbi isolates tested as determined by Pearson's correlation 
study was also statistically significant (Pearson Coefficient 
villue of ~-Oil- Correlation studies also showed an inverse 
relationship between antimicrobial susceptibilities by both the 
above described methods (Table II). Reduced zone diameters 
~y "disc diffusion method correlate well with the increasing 
MIC values for the given antibiotic even if the isolate is shown 
to be fluoroquinolone susceptible by disk diffusion method as 
per NCCLS recommendations. 
Table II: Correlation between nalidixic acid disk and ofloxacin MIG 
values. (*Significance, **N. Number of isolates, ***Correlation is 
significant at the level of 0.01 level (2-tailed). 
Nalidixic acid disc(mm) Pearson correlation 
Sig'. (2-tailed) 
w· 
Ofloxacin MIG (#g/ml) Pearson correlation 
Sig•. (2-tailed) 
N .. 
Nalidixic acid 
disc(mm) 
200 
-0.924 ... 
0.00 
200 
Ofloxacin 
MIG (pg/ml) 
-0.924''' 
0.00 
200 
200 
!able Ill: Correlation between ofloxacin disk and ofloxacin MIC values. 
<; (*Significance, ""*N. Number of isolates, .... *Correlation is 
significant at the level of O.Q1 level (2-tailed). 
Of!oxacin Ofloxacin 
-
disc(mm) MIG (pg/ml) 
Ofloxacin disc(mm) Pearson correlation 1 -0.899 ... 
Slg'. (2-tailed) 0.00 
-
N" 200 200 
Oiioxac;n MIG (pg/ml) Pearson correlation -0.899' .. 
Sig'. (2-tailed) 0.00 
N .. 200 200 
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All the isolates for which ofloxacin M!Cs were ::B-125 /'g/rnl 
showed no zone of inhibition around nalidixic acid by disc 
diffusion test MIC of nalidixic acid for these isolates were 
>32/'g/mL In contra,st 99 out of 100 isolates which had MIC 
value of ofloxacin <0.1251'g/ml (0.3-0.6 !'g/ml) had inhibition 
zone diameter around nalidixic 'acid disk 2:20mm. MIC value 
of nalidixic acid for these isolates were,; 8 !'g/ml. Based on 
the MIC value and disk diffusion results, screening for 
nalidixic acid resistance has led to the detection of all S. typbi 
strains with reduced susceptibility to ofloxacin (MIC values 
2:0.125f!g/ml). These results fairly correlate the higher MIC 
values for isolates resistant to nalidixic acid by both the 
screening methods. Sensitivity of nalidixic acid screening 
'method was calculated to be 100% in detecting S. typbi isolates 
with decreased fluoroquinolone susceptibility (MIC ;, 
0.125f!g/ml) with the specificity approaching 97%. 
DISCUSSION 
Fluoroquinolones and third generation cephalosporins 
. (ceftriaxone, cefixirne) are found to have maximum activity 
against multidrug resistantS. typbi isolates with the reported 
resistant rate of less than 2%.13,14,22 
With the emergence of these MDR strains, fluoroquinolones 
became the agent of choice in treatment of uncomplicated· 
typhoid fever. Several studies have compared the efficacy of 
short course oral treahnent with fluoroquinolone (ofloxacin, 
ciprofloxacin) and third generation cephalosporin (cefixime, 
ceftriaxone)_S,B-10 In almost all of the studies short course 
treatment with oral ofloxacin (5 days) was reported to be 
significantly better than ceftriaxone particularly in areas 
where MDR Salmonella typbi is prevalent thus favoring the 
widespread use of fluoroquinolone in the community for 
treating enteric fever. 
Investigators from Vietnam first reported the isolation of 
nalidixic acid resistant S. typbi in 1993.17 The M!Cs of 
ciprofloxacin for these nalidixic acid resistant isolates were 
higher as compared to nalidixic acid sensitive isolates, 
although, the M!Cs were still within the current NCCLS range 
for susceptibility (i.e 0.125-0.Sf!g/ml). Disk diffusion method 
failed to detect these isolates as all were interpreted as 
fluoroquinolone susceptible, A growing body of clinical and 
microbiological evidence indicates that such nalidixic acid 
resistant Salmonella infections exhibit a decreased clinical 
response to fluoroquinolones,1B,23,24 Cure rates achieved by 
fluoroquinolone treatment in patients infected with nalidixic 
acid resistant strains were only 50% as compared to 97% for 
patients infected by nalidixic acid sensitive strains.l' Hence, 
authors recommended that laboratories must test 
extraintestinal Salmonella isolates for nalidixic acid resistance 
and NCCLS fluoroquinolone breakpoints for Salmonella should 
be re-evaluated." 
Screening test using nalidixic acid disk diffusion test as 
evaluated further by various authors1B-20 is demonstrated to be 
_highly sensitive and specific for detecting Salmonella isolates 
with decreased susceptibility to fluoroquinolones (MIC 2: 
0.125ug/ml), 
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The primary objective of this study was to explore and 
validate nalidixic acid susceptibility as a screening method to 
detect 5. typbi strains with high MIC to ofloxacin. Our findings 
were consistent with the previously published results.19-21 
Among 200 5. typhi isolates evaluated, two distinct sub-
populations were identified when isolates susceptible to 
ofloxacin by NCCLS criteria were tested for nalidixic acid 
susceptibility by disc diffusion method, nalidixic acid 
sensitive and nalidixic acid resistant 5. typbi. The MIC of 
ofloxacin for nalidixic acid resistant isolates were higher (;;;:: 
O.l25f!g/ml) than those for nalidixic acid sensitive isolates (:5 
0.06f!g/ ml). All nalidixic acid resistant isolates had no zone of 
inhibition around 30f!g nalidixic acid disk. 
Based on these observations nalidixic acid screening test was 
found to be highly sensitive in the detection of strains with 
decreased susceptibility to fluoroquinolones. Studies with 
similar results have recommended that in addition to the 
categories of resistant and fully susceptible, a category of 
decreased fluoroquinolone susceptibility could be useful in 
the susceptibility determinations of 5almonella.l• Recent 
recommendations by working party BSAC (British Society of 
Antimicrobials and Chemotherapy) for standard disc 
susceptibility testing method also states that in testing 
Sabnonella species for ciprofloxacin susceptibility there is 
clinical evidence to indicate poor response in systemic 
infections caused by Salmonella species with reduced 
susceptibility to fluoroquinolones (ciprofloxacin M!C 0.125-1 
mg/L). This reduced susceptibility is most reliably detected 
with nalidixic acid 30/lg discs as strains with reduced 
susceptibility show no zone of inhibition." 
Our second objective was to correlate zone diameters of 
ofloxacin for both nalidixic acid sensitive and resistant strains 
to define a cut-off value that can fairly be associated with 
decreased fluoroquinolone susceptibility with MIC value of 
2:0.125f!g/ml. All 5. typbi isolates which were nalidixic acid 
sensitive had inhibition zone diameter of :225mm around S~g 
ofloxacin disk with MIC ofloxacin 0.03-0.06f!g/ml, hence 
ofloxacin susceptible. All these isolates were also susceptible 
to nalidixic acid (mean zone diameter of24.9 ±2.1). In contrast, 
all 100 isolates with inhibition zone diameter of :525mm by 
disk diffusion method had an MIC of 2: 0.125f!g/ml for 
ofloxacin (Figure 2). These isolates were resistant to nalidixic 
acid with no zone of inhibition around nalidixic acid disk. The 
mean zone of inhibition around S~g ofloxacin disk for 100 
nalidixic acid sensitive isolates, as observed in this study was 
27.7 ± 2.6 mm, a size significantly greater than nalidixic acid 
resistant strains with inhibition zone diameter 22.6 ± 1.5mm. 
These results establish the association between nalidixic acid 
resistance, higher MIC values and a significant difference in 
zone diameter for ofloxacin. It is important for microbiological 
laboratories to recognize these less susceptible isolates by 
performing nalidixic acid susceptibility as a screening method 
for all 5. typbi strains isolated from blood culture samples in 
order to help clinicians to initiate appropriate alternative 
antimicrobial therapy. 
CoNCLUSION 
Nalidixic acid susceptibility as a screening methodology was a 
highly sensitive and specific in identifying S. typbi isolates with 
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MIC value of 2:0.12Sf!g/ml in our series. A zone diameter 01 
:5 25 mm around Sf!g ofloxacin disk is appropriate as , ' 
selection criterion to detect almost all Salnwnella isolates With 
decreased susceptibility to fluoroquinolone. 
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